|
Molecular properties generated using the CDK |
Classification ![]() |
|
| Compound class | Synthetic organic |
| Approved drug? | Yes (source: FDA (2007), EMA (2008)) |
IUPAC Name ![]() |
| (2S)-2-(4,6-dimethylpyrimidin-2-yl)oxy-3-methoxy-3,3-di(phenyl)propanoic acid |
International Nonproprietary Names ![]() |
|
| INN number | INN |
| 8128 | ambrisentan |
Synonyms ![]() |
| Letairis® |
Database Links ![]() |
|
| CAS Registry No. | 177036-94-1 (source: Scifinder) |
| ChEBI | CHEBI:254051 |
| ChEMBL Ligand | CHEMBL1111 |
| PubChem CID | 6918493 |
| Search Google for chemical match using the InChIKey | OUJTZYPIHDYQMC-LJQANCHMSA-N |
| Search Google for chemicals with the same backbone | OUJTZYPIHDYQMC |
| Search PubMed clinical trials | ambrisentan |
| Search PubMed titles | ambrisentan |
| Search PubMed titles/abstracts | ambrisentan |
| Wikipedia | Ambrisentan |
| Comments |
| Ambrisentan is an endothelin receptor antagonist, with selectivity for the type A endothelin receptor (ETA). |